Weight loss is not enough to treat dyslipidemia in women

Published Date: 06 Mar 2023

Obesity continues to exist around the world despite the risk to health and death from illness and disease.

Read Full News

Latest News

Are Beef Tallow and Zone 2 Training Worth the Hype?

Evidence supports replacing saturated fat with unsaturated fat and improving cardiorespiratory fitness, but neither trend has evidence for the categorical claims made online.

Dengue Patients on DAPT or OAC Face More Frequent Bleeding

Among patients with acute dengue infection, those already on dual antiplatelet or oral anticoagulant therapies experience major bleeding more often than those not on antithrombotic therapy.

Heart Imaging Measures May Flag SCD Risk in HFmrEF

The extent of late gadolinium enhancement and tissue damage on cardiac imaging may help predict risk for sudden cardiac death in patients with heart failure with mildly reduced ejection fraction.

SCA Shown to Strike Young Athletes Mostly During Training, Practice

A new study highlights the need to expand emergency response efforts for sudden cardiac arrest in young athletes.

Antiplatelet Therapy vs Thrombolysis in Spinal Infarction

In spontaneous spinal cord infarction, standard antiplatelet therapy was associated with significantly lower all-cause mortality compared with thrombolytic treatment.

Early Menopause Leaves Lasting Trace on Brain

Todays Updates

Saturated Fat Tied to Worse Survival After Prostate Cancer

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Medication Self-Injection Embraced by Breast Cancer Patients

Women with breast cancer show interest in self-injecting their medication.

Todays Updates

Saturated Fat Tied to Worse Survival After Prostate Cancer

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Medication Self-Injection Embraced by Breast Cancer Patients

Women with breast cancer show interest in self-injecting their medication.

Latest News

Evidence supports replacing saturated fat with unsaturated fat and improving cardiorespiratory fitness, but neither trend has evidence for the categorical claims made online.

Among patients with acute dengue infection, those already on dual antiplatelet or oral anticoagulant therapies experience major bleeding more often than those not on antithrombotic therapy.

The extent of late gadolinium enhancement and tissue damage on cardiac imaging may help predict risk for sudden cardiac death in patients with heart failure with mildly reduced ejection fraction.

A new study highlights the need to expand emergency response efforts for sudden cardiac arrest in young athletes.

In spontaneous spinal cord infarction, standard antiplatelet therapy was associated with significantly lower all-cause mortality compared with thrombolytic treatment.

News All Time

Certain Social Factors Tied to Metabolic Liver Disease

Food insecurity and neighborhood deprivation were each independently associated with higher incidence of MASLD, with the highest incidence among adults experiencing both.

Sports Unite Doctors in Spain and Beyond

Medical soccer, cycling, and marathon running are helping physicians build camaraderie, stay active, and strengthen professional networks beyond the hospital.

Deep Dive: Two New Drugs, One Disease: MASLD's Three-Specialty Shift

Beyond Gastroenterology: FDA Approvals and Updated Guidelines Shift Frontline MASLD Care to Primary Medicine and Endocrinology

As GLP-1s Revolutionize Obesity Care, Access Remains Uneven

GLP-1 drugs have moved rapidly into the mainstream, but recent data show that many ideal patients are still being left behind.

The Secret Weapon That Eliminated Doubt I Was a Good Doctor

A hematologist oncologist came from humble roots in a different culture and had to learn what internal strengths she possessed to succeed in medicine. She never looked back.

Mechanical VT Risk Factors Tied to Young Stroke

Recent mechanical venous thrombosis risk factors are linked to cryptogenic ischemic stroke in younger adults, particularly those with patent foramen ovale, study shows.

Clonal Hematopoiesis Tied to Brain Damage in AF

In patients with atrial fibrillation, clonal hematopoiesis was linked to hidden brain damage and faster mental decline over 7 years.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Heart Failure Drug May Not Improve Exercise Fitness in nHCM

A heart failure drug combination may not improve exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy but is associated with favorable cardiac structural remodeling.

DOACs Benefit AF Patients With Intermediate Stroke Risk

Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an apparent increase in major bleeding.